Miami, FL – July 1, 2019 ( NewsWire) —, a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies, reports on BioElectronics Corporation (OTC Pink: BIEL).

BioElectronics Corporation develops and markets disposable, drug-free, pain therapy, and wearable medical devices worldwide. Its products include ActiPatch therapy for over-the-counter treatment of back pain and other musculoskeletal complaints; Smart Insole for heel pain relief; Allay for menstrual pain relief; RecoveryRx for chronic and post-operative wound care; and HealFast therapy, a drug-free therapy for healing of muscle and tendon injuries, sores, and incisions in horses, cats, and dogs.

Average daily volume for BIEL 42 million shares. Today’s news has caused the volume to increase to over 617 million shares in the morning hours of trading.

BioElectronics Corporation Press Release:

FREDERICK, MD, July 01, 2019 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — BioElectronics Corporation (OTC PINK: BIEL),, the maker of non-invasive electroceutical devices, is pleased to announce that it has received market clearance from the United States Food and Drug Administration (US FDA) for its RecoveryRx® medical device, for the treatment of postoperative pain.

Physicians are discarding opioid-centric pain management, instead focusing on a multimodal approach of two or more analgesic therapies to decrease the use of opioids and to achieve more effective pain control [1]. Currently, less than 50% of patients who undergo surgery report adequate postoperative pain relief [2]. RecoveryRx will be an ideal choice in reducing postoperative pain and exposure to long-term effects of opioid/NSAID therapy.

RecoveryRx is a superior, drug-free, safe therapy and will be available to the 15 million Americans who experience postoperative pain from 25 million surgeries, annually [3]. Additionally, debridement and negative vac therapy treatments among the 7 million chronic wound patients are a significant market opportunity for RecoveryRx therapy.

Andrew Whelan, President, expressed confidence in seizing the market opportunity: “We are delighted that the FDA has recognized the potential of RecoveryRx in transforming postoperative pain care. RecoveryRx, with its high degree of safety, excellent clinical evidence of effectiveness and exceptional cost-benefit, will become the standard of care.”

As a side note, the Company is preparing documentation for its ActiPatch® 510(k) application to seek expanded indications of treating general musculoskeletal pain and intends to file within the next few weeks.

About BioElectronics Corporation

BioElectronics Corporation is a leader in non-invasive electroceuticals and the maker of an industry leading family of disposable, drug-free, pain therapy devices: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; Allay® Menstrual Pain Therapy. For more information, please visit


[1] Stavros, G. Memtsoudis, “Association of Multimodal Pain Management Strategies with Perioperative Outcomes and Resource Utilization: A Population -based study,” Anesthesiology, vol. 28, no. 5, pp. 891-902, 2018.

[2] Chou, Roger, “Guidelines on the Management of Postoperative Pain,” American Pain Society, vol. 17, no. 2, pp. 131-157, 2016.

[3] Steiner, Claudia A (AHRQ);, “Surgeries in Hospital-Based Ambulatory Surgery and Hospital Inpatient Settings, 2014,” AHRQ, February 2018 (Revised). [Online]. Available:

Paul Knopick

About is a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth markets and companies.  Through its evolution, found a niche in identifying companies that can be overlooked by the markets due to, among other reasons, trading price or market capitalization.  We look for strong management, innovation, strategy, execution, and the overall potential for long- term growth.  Aside from being a trusted resource for the Emerging Growth info-seekers, we are well known for discovering undervalued companies and bringing them to the attention of the investment community.  Through our parent Company, we also have the ability to facilitate road shows to present your products and services to the most influential investment banks in the space.

All information contained herein as well as on the website is obtained from sources believed to be reliable but not guaranteed to be accurate or all-inclusive. All material is for informational purposes only, is only the opinion of and should not be construed as an offer or solicitation to buy or sell securities. The information may include certain forward-looking statements, which may be affected by unforeseen circumstances and / or certain risks., or its associates may have a position either long or short in any company mentioned herein. Please read our full disclosure, which can be found here, Please consult an investment professional before investing in anything viewed within this article or any other portion of In addition, please make sure you read and understand the Terms of Use, Privacy Policy and the Disclosure posted on the website.

Add a Comment to this Post